Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peri-implantitis - Regenerative Treatment With Enamel Matrix Derivative (EMD). Clinical Effects, Microbial Profiles and Molecular Mechanisms. A Randomised Controlled Pilot Study.

NCT02500654 is registered in ClinicalTrials.gov with Catrine Isehed as lead sponsor.

NCT NCT02500654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02500654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peri-implantitis - Regenerative Treatment With Enamel Matrix Derivative (EMD). Clinical Effects, Microbial Profiles and Molecular Mechanisms. A Randomised Controlled Pilot Study.
Lead sponsor
Catrine Isehed
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2008
Completion date
January 31, 2014
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections, bleeding of subgingival space, failure of dental implant due to infection, infection, inflammation, molecular sequence variation, mouth diseases, peri-implantitis, periodontal diseases